Back to Directory
Shield Therapeutics
North East England
Founded 2008
Oral iron deficiency therapy for adults across multiple indications
Shield Therapeutics is a commercial-stage specialty pharmaceutical company focused on iron deficiency.
Its lead product, Accrufer/Feraccru (ferric maltol), is an oral iron therapy approved for adults with iron deficiency with or without anaemia.
The product is commercialised in the US with Viatris and licensed to partners including Norgine, ASK Pharm and KYE Pharmaceuticals across other major markets.